背信 发表于 2025-3-23 12:25:03

Submitted on: 27 May 2021.
Revised on: 07 July 2021.
Accepted on: 20 July 2021.

___________________Contemporary Clinical Trials Communications

MOCK 发表于 2025-3-23 16:54:47

Submitted on: 09 August 2001.
Revised on: 20 September 2001.
Accepted on: 25 October 2001.

___________________Contemporary Clinical Trials Communications

激励 发表于 2025-3-23 18:40:04

http://reply.papertrans.cn/1/65/6427/6427-13.png

粗糙滥制 发表于 2025-3-23 22:58:31

Submitted on: 10 February 2017.
Revised on: 11 May 2017.
Accepted on: 24 May 2017.

___________________Contemporary Clinical Trials Communications

金哥占卜者 发表于 2025-3-24 04:38:26

http://reply.papertrans.cn/1/65/6427/6427-15.png

注视 发表于 2025-3-24 07:03:33

Submitted on: 28 October 2009.
Revised on: 18 December 2009.
Accepted on: 31 January 2010.

___________________Contemporary Clinical Trials Communications

Blasphemy 发表于 2025-3-24 13:46:56

http://reply.papertrans.cn/1/65/6427/6427-17.png

青石板 发表于 2025-3-24 15:19:01

http://reply.papertrans.cn/1/65/6427/6427-18.png

拒绝 发表于 2025-3-24 19:36:40

http://reply.papertrans.cn/1/65/6427/6427-19.png

大洪水 发表于 2025-3-25 01:52:31

Submitted on: 13 November 2020.
Revised on: 01 January 2021.
Accepted on: 26 January 2021.

___________________Contemporary Clinical Trials Communications
页: 1 [2] 3 4
查看完整版本: ESCI期刊Contemporary Clinical Trials Communications 2024/2025影响因子:1.461 (CONT CLIN TRIAL COMM) (NULL). (MEDICINE, RESEARC